
Biological Activity
Allosteric glycogen phosphorylase inhibitor; acts at the indole site of glycogen phosphorylase. Inhibits glucagon-mediated hyperglycemia in vivo in the rat.
Licensing Information
Sold with the permission of AstraZeneca UK Ltd.
Compound Libraries
GPi 688 is also offered as part of the Tocriscreen Plus. Find out more about compound libraries available from Tocris.
Technical Data
M. Wt | 419.88 |
Formula | C19H18ClN3O4S |
Storage | Store at +4°C |
Purity | ≥99% (HPLC) |
CAS Number | 918902-32-6 |
PubChem ID | 10477191 |
InChI Key | UICNBXVDHCBKCE-PUODRLBUSA-N |
Smiles | OC[C@H](O)CN(C1=CC=CC=C1CC2NC(C3=CC4=C(SC(Cl)=C4)N3)=O)C2=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Solubility Data
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 41.99 | 100 | |
ethanol | 10.5 | 25 |
Preparing Stock Solutions
The following data is based on the product molecular weight 419.88. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.38 mL | 11.91 mL | 23.82 mL |
5 mM | 0.48 mL | 2.38 mL | 4.76 mL |
10 mM | 0.24 mL | 1.19 mL | 2.38 mL |
50 mM | 0.05 mL | 0.24 mL | 0.48 mL |
Molarity Calculator
Reconstitution Calculator
Dilution Calculator
Product Datasheets
References
References are publications that support the products' biological activity.
Freeman et al (2006) Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme. Br.J.Pharmacol. 149 775 PMID: 17016495
Poucher et al (2007) An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia. Br.J.Pharmacol. 152 1239 PMID: 17934512
Keywords: GPi 688, supplier, GPi688, glycogen, phosphorylase, inhibitors, hyperglycaemia, hyperglycemia, inhibits, astrazeneca, Phosphorylases, Phosphorylases, Tocris Bioscience